Dawn of Aurora kinase inhibitors as anticancer drugs

Author： Doggrell Sheila A  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.13, Iss.9, 2004-09, pp. : 1199-1201

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Protein kinase C inhibitors as novel anticancer drugs

By Jirousek Michael R   Goekjian Peter G  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 12, 2001-12 ,pp. : 2117-2140

Informa Healthcare

Access to resources Recommend Favorite

Cyclin-Dependent Kinase Inhibitors as Anticancer Drugs

By  

Current Drug Targets, Vol. 11, Iss. 3, 2010-03 ,pp. : 291-302

Bentham Science Publishers

Access to resources Recommend Favorite

Aurora kinase inhibitors: identification and preclinical validation of their biomarkers

By Carpinelli Patrizia   Moll Jürgen  

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 1, 2008-01 ,pp. : 69-80

Informa Healthcare

Access to resources Recommend Favorite

Aurora kinase inhibitors in preclinical and clinical testing

By Cheung Chun Hei Antonio   Coumar Mohane Selvaraj   Hsieh Hsing-Pang   Chang Jang-Yang  

Expert Opinion on Investigational Drugs, Vol. 18, Iss. 4, 2009-04 ,pp. : 379-398

Informa Healthcare

Access to resources Recommend Favorite

Aurora-B Kinase Inhibitors for Cancer Chemotherapy

By  

Mini Reviews in Medicinal Chemistry, Vol. 8, Iss. 14, 2008-12 ,pp. : 1514-1525

Bentham Science Publishers

Access to resources Recommend Favorite